« Back
Home /
SMAD1 Recombinant Protein

SMAD1 Recombinant Protein

Item no.	OPCD07060
Manufacturer	AVIVA Systems Biology
Amount	10 ug
Category	Oncology Neuroscience Targets for Rodent Neurosciences By Cell Type Blastoma Carcinoma Hematology Leukemia Lymphoma Sarcoma Peptides & Proteins Recombinant Proteins Adenocarcinoma Immunoprecipitation Western Blot ELISA SDS-PAGE By Organ Colorectal Cancer
Type	Proteins Recombinant
Applications	WB, SDS-PAGE
Specific against	Rat (Rattus norvegicus)
Host	E.coli
Conjugate/Tag	Unconjugated; HIS
Purity	> 95%
ECLASS 10.1	32160409
ECLASS 11.0	32160409
UNSPSC	12352202
Alias	MAD (mothers against decapentaplegic,Drosophila) homolog 1;MAD homolog 1;MAD homolog1 (mothers against decapentaplegic,Drosophila);Madh1;mothers against decapentaplegic homolog 1;mothers against DPP homolog 1;SMAD 1;SMAD family member 1;SMAD,mothers against DPP homolog 1.
Available
Manufacturer - Type	Protein
Manufacturer - Applications	Positive control\|Sodium sodecyl sulfate - polyacrylamide gel electrophoresis\|Western blot
Manufacturer - Category	Root Catalog/Products/Recombinant Proteins
Manufacturer - Conjugate / Tag	N-terminal His Tag
Molecular Weight	23.41kDa
Gene symbol	Smad1
Gene Fullname	SMAD family member 1
Protein size	Recombinant
Product format	Freeze-dried Powder. PBS, pH7.4, containing 0.01% SKL, 5% Trehalose.
Reconstitution and storage	2°C to 8°C\|-80°C
Description of target	Transcriptional modulator activated by BMP (bone morphogenetic proteins) type 1 receptor kinase. SMAD1 is a receptor-regulated SMAD (R-SMAD). Has been shown to be also activated by TGF-beta (transforming growth factor) type I receptor kinase in rat intestinal epithelial cells (IEC 4-1). SMAD1/OAZ1/PSMB4 complex mediates the degradation of the CREBBP/EP300 repressor SNIP1. May act synergistically with SMAD4 and YY1 in bone morphogenetic protein (BMP)-mediated cardiac-specific gene expression (By similarity).
Protein name	Mothers against decapentaplegic homolog 1
Formulation	PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
Concentration	200 ug/mL (prior to lyoph)

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

OPCD07060-datasheet.pdf

Request safety datasheet

Simple Order Order Subscription

Amount: 10 ug

available

Delivery expected until 11/13/2025

Express Delivery: Save 13 days

Compare

Add to wishlist

Get an offer